HDAC inhibitors are a class of anti-cancer agents that suppress tumor cell growth via a broad spectrum of mechanisms including the ability to induce growth arrest, differentiation, and apoptosis in cancer cells [12–17]. The gene discussed is HDAC9; the disease is neoplasm.